Hello, it looks like you are visiting from United States / Estados Unidos Language US Go to United States (English) / Estados Unidos (español) site

MiYOSMART is the innovative solution for slowing down myopia progression in an easy, safe, effective non-invasive way, so your child can race full-steam ahead.

Myopia is a global concern.

An estimated 5 billion people, or half the global population could be affected by myopia by 2050*

 

Annual myopia progression rate is most rapid under 10 years of age. Significantly greater rates of progression can be seen especially in children with high myopia.

If left untreated, myopia can lead to lasting vision problems.

But together we can tackle myopia in children

An innovative spectacle lens.

 

Together with The Hong Kong Polytechnic University, Hoya Vision Care developed the first spectacle lens with Defocus Incorporated Multiple Segments (D.I.M.S.) Technology that manage myopia progression.

This technology is based on the peripheral defocus theory.

A myopia management solution backed by research.

A revolutionary technology.

 

With the exclusive non-invasive D.I.M.S. Technology, the lens corrects the visual defect on its entire surface and has a ring shaped treatment area to slow down myopia progression. The alternation of the focus area and defocus area provides clear vision and manages myopia simultaneously.

Scientific Evidence of MiYOSMART

2-year Randomized Clinical Trial

Defocus Incorporated Multiple Segments (DIMS) lenses slow myopia progression: a 2-year randomized clinical trial (BJO)

Read the full study

3-year Follow-up Study

Myopia control effect of defocus incorporated multiple segments (DIMS) lens in Chinese children: results of a 3-year follow-up study (BJO)

Read the full study

6-year Follow-up Study

Long-term myopia control effect and safety in children wearing DIMS lenses for 6 years

Read the full study

Designed to fit a child’s active life.

 

MiYOSMART comes with an easy-to-wipe special anti-reflective, durable coating. With its Eye Shield, young patients get the added assurance of an impact resistant material and full UV protection.

*Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resniko S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. American Academy of Ophthalmology. 05/2016, vol.123, no. 5, p.1036–1042.
1. Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/ bjophthalmol-2018-313739
2. Brien Holden Vision Institute; 2 Shanghai Eye Disease Prevention and Treatment Center https://guidelines.brienholdenvision.org, accessed 16.08.1018.

*PRODUCT DISCLAIMER – MiYOSMART has not been approved for myopia management in all countries, including the U.S., and is not currently available for sale in all countries, including the U.S.